Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2022 Jan 12:S2213-2198(22)00003-4. doi: 10.1016/j.jaip.2021.12.031

Figure 5.

Figure 5

Subjects with variability that exceeded 20+2 had basal tryptase values graphed ordinally. Horizontal dashed lines represent the threshold of the formula using the lowest tryptase value. Shaded regions corresponded to concurrent use of imatinib, prednisone, or hydroxyurea. (a) HαT (b) no associated diagnosis (c) SM-PV (d) mastocytosis (e) multiple diagnoses (f) CKD.